Pfizer Launches Newly Combined CMO
PTSM: Pharmaceutical Technology Sourcing and Management
Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.
Pfizer’s newly combined global CMO, Pfizer CentreOne, launched on April 20, 2016. The CMO will focus specifically on API synthesis and sterile injectables fill-finish, Pfizer said in a press announcement.
Pfizer CentreOne was formed by the combination of Pfizer CentreSource and Hospira One 2 One. The formation comes after Pfizer acquired One 2 One in September 2015. The newly formed CMO plans to combine Pfizer’s knowledge of specialty APIs with One 2 One’s work with sterile injectables.
Pfizer CentreOne’s core offerings will include:
- Small-molecule steroid and hormone intermediates and APIs
- Custom small-molecule API synthesis
- Sterile injectables fill-finish.
“As a combined organization, we’ve brought together the best of our manufacturing capabilities to provide a wider array of services and technologies to our biopharmaceutical partners,” said Peter Stevenson, vice-president and general manager of Pfizer CentreOne, in a press announcement. “Although Pfizer CentreOne is a new name, we’ve been providing contract manufacturing services for more than 40 years and are committed to further growing our business.”
Source: Pfizer
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
